{
    "2018-01-02": [
        [
            {
                "time": "",
                "original_text": "医疗保健：同时明确首家生物类似药为高 荐14股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "生物类似药",
                        "荐股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "保健",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "生物制品行业:博生吉安科产品获CDE受理,行业发展提速",
                "features": {
                    "keywords": [
                        "生物制品",
                        "CDE受理",
                        "行业发展",
                        "提速"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}